Board of Directors

Sarah Dash is the president and CEO of the Alliance for Health Policy. She joined the Alliance in April 2014 as vice president for policy. Prior to joining the Alliance, she was a member of the research faculty at the Georgetown University Health Policy Institute in the Center on Health Insurance Reforms. She has also served as a senior health policy aide on Capitol Hill. She received her master’s in public health from Yale University and a bachelor’s of science degree from the Massachusetts Institute of Technology.

Tanisha Carino, Ph.D. is a partner with the Brunswick Group, an advisory firm that helps clients navigate the interconnected financial, political, and social worlds to build trusted relationships with all their stakeholders. She is a corporate affairs and health policy expert who brings over 20 years of experience across multiple healthcare leadership positions in government, private, and non-profit sectors. Prior to joining Brunswick, Tanisha held executive roles as the first Chief Corporate Affairs Officer of Alexion, Executive Director of FasterCures/Milken Institute, led US public policy at GlaxoSmithKline, and was the head of life sciences strategic advisory services for Avalere Health. She began her career as an HIV case worker in Atlanta and a policy researcher in the Medicare program. Dr. Carino is a Fulbright Fellow, has served as a Visiting Fellow for the White House Office of Science and Technology Policy, and earned her doctorate in health policy from Johns Hopkins University. She is associate faculty at the Johns Hopkins Bloomberg School of Public Health, a Visiting Fellow for the Duke-Margolis Health Policy Center, serves on the Board of Directors of Silk Road Medical, One Mind, and is the Vice-Chair of the Alliance for Health Policy.

Adaeze Enekwechi is an operating partner at Welsh, Carson, Anderson and Stowe, an investment firm where she focuses on growth-oriented healthcare companies. She also brings a focus on the policy and regulatory environment which can have an outsize impact on healthcare investments. Dr. Enekwechi is trained in healthcare economics and outcomes research, and led IMPAQ, LLC, a company that provided research, technical assistance, and advanced analytics services for government clients which she took through its acquisition in 2020. In addition to her private sector experience, she spent many years in federal policy roles at the Congressional Budget Office (CBO), the Medicare Payment Advisory Commission (MedPAC) and as the head of Health Programs at the White House Office of Management and Budget (OMB) under President Obama. There she led policy, management and regulatory oversight for over $1 trillion in spending across all federal health agencies and programs. Dr. Enekwechi also serves on the board of directors at the Public Health Institute, UnityPoint Health System, and Tia, a women’s health company.

Dianne Faup is a founding partner at Speire Healthcare Strategies, a boutique healthcare consulting firm that provides strategic advisory services at the intersection of policy and strategy. She has over 25 years of experience working in the health care industry as an attorney, a management consultant, and a government executive. Previously, she held senior leadership positions in Booz Allen Hamilton and KPMG Europe and served as a senior advisor to then-Deputy Secretary Alex Azar of the U.S. Department of Health & Human Services and chief of staff of the District of Columbia Department of Health Care Finance. Ms. Faup holds a bachelor’s degree in management from Manhattanville College and a juris doctorate from the University of New Hampshire (Franklin Pierce Law).

Vicky Gregg has a deep experience in health care ranging from direct patient care to her long tenure as a chief executive spans hospital administration, long-term care, and health care benefits and financing. Currently she is a co-founder of Guidon Partners, GP, LLC since November 2014. Ms. Gregg served as the chief executive officer of BlueCross BlueShield of Tennessee from January 2003 to December 2012. She served as market vice president for Humana in Kentucky, Ohio, and Indiana prior to joining BlueCross. Ms. Gregg was appointed by Senate Majority Leader Bill Frist to the National Institutes of Health Commission on Systemic Interoperability, served on the Boards of the BlueCross BlueShield Association and America’s Health Insurance Plans, including two years as Chair, the National Institute of Healthcare Management (NIHCM), and the Board of the University of Tennessee.

Elizabeth Hall is the vice president of public policy and issues management at Elevance Health. Ms. Hall and her staff work closely with business unit leaders, senior executives, and internal subject matter experts to develop enterprise positions on federal and state legislation as well as federal regulations related to our core business. From 2010 – 2021, she served as the company’s vice president of Federal Affairs. Prior to joining Elevance Health, Ms. Hall served as the director of the Office of Legislation at the Centers for Medicare & Medicaid Services at the U.S. Department of Health and Human Services. She also worked for Sen. Bill Frist (R-Tenn.) in Congress. She has a bachelor’s in sociology from the University of Pennsylvania.

Demetrios L. Kouzoukas has deep experience in every health care sector and spanning business, law, and government. He is a partner at the Team8 Health venture foundry, a member of the Board of Directors of Clover Health, director of Paragon Health Institute’s Medicare Initiative, and a member of the American Medical Association Digital Medicine Payment Advisory Group. From 2017 to 2021, Kouzoukas served as the chief executive of the Medicare program at the Centers for Medicare and Medicaid Services (CMS). In that role, he worked with patients, policymakers, providers, insurers, and manufacturers to improve health care in the United States. Prior to joining CMS, Demetrios was a senior executive at UnitedHealthcare’s Medicare business. He has also served as Principal Associate Deputy Secretary and as Deputy General Counsel of the U.S. Department of Health and Human Services, working with every part of the Department’s portfolio. He has built innovative practices focused on new regulations and business models at two leading health care law firms. In addition, he has represented the public as an expert in public administration and health benefits as an appointee to the Administrative Conference of the United States.

Margaret Murray is the founding CEO of the Association for Community Affiliated Plans (ACAP). Prior to leading ACAP, Mrs. Murray was the Medicaid director in New Jersey and oversaw the expansion of the FamilyCare program to cover all children under 350 percent of poverty. She was also a senior budget analyst for the U.S. Office of Management and Budget. She has served the Institute of Medicine’s Committee on the Public Financing and Delivery of HIV Care, the Maryland Community Health Resources Commission and on the board of a Community Health Center in Southern Maryland. She received her master’s in public affairs from the Woodrow Wilson School of Princeton University and her bachelor’s cum laude in economics and classical civilization from Wellesley College.

Dan Mendelson is CEO, Morgan Health, of JPMorgan Chase & Co. He was previously founder and CEO of Avalere Health, a healthcare advisory company based in Washington D.C. Dan also served as operating partner at Welsh Carson, a private equity firm. Before founding Avalere, Dan served as associate director for Health at the Office of Management and Budget in the Clinton White House. Dan currently serves on the board of Champions Oncology (CSBR) and is adjunct professor at the Georgetown University McDonough School of Business. He previously served on the boards of Coventry Healthcare, HMS Holdings, Pharmerica, Partners in Primary Care, Centrexion, and Audacious Inquiry. He holds a bachelor’s from Oberlin College, and a master’s in public policy from the Kennedy School of Government at Harvard University.

Mike Park is a partner in Alston & Bird’s Health Care Legislative & Public Policy Group. He has more than 20 years of health law and policy experience. He focuses his practice on representing health care providers, insurers, and manufacturers before Congress and the administration on a wide range of health care legislative and regulatory issues and also counsels clients in connection with congressional investigations. Before joining Alston & Bird, Mr. Park served as health policy counsel to Senator Charles Grassley (R-IA) during his tenure as Chairman of the Senate Committee on Finance, where he developed legislation on issues including Medicare payment policy, health information technology, and program integrity and conducted congressional investigations on public and private health care stakeholders. Mr. Park also served as a policy coordinator in the U.S. Department of Health and Human Services Office of the Secretary, as a project officer for Medicare payment demonstration programs at the Centers for Medicare & Medicaid Services, and as a health research analyst at the Center for Studying Health System Change. He currently serves as an adjunct faculty member at George Washington University’s School of Public Health. He received his bachelor’s degree from Connecticut College, his juris doctorate degree from Penn State Dickinson School of Law, and his master’s in public health from Columbia University.

Marc Samuels is founder and CEO of ADVI Health, a health care and life sciences advisory and consulting services firm headquartered in Washington, DC that helps clients accelerate growth, trailblaze innovation, and expand coverage of products and services. Marc also founded the firm’s life science accelerator, adviLAB, to invest in digital therapy, AI, MedTech, and cell and gene therapy clients in early stages of development. Marc has played a role in over 200 product and service projects over the last two decades from cell and gene, to rare and ultra-rare to oncology, and digital therapies. Marc has worked widely across the US health care system to improve regulatory and payer policy, promote appropriate clinical outcomes, and highlight the importance of the patient experience. Before founding ADVI, Marc was a partner in HillCo Partners, an Austin-based public affairs and advocacy company. He served both President George W. Bush and George H.W. Bush at the Texas Health and Human Services Commission, the Governor’s Policy Office, the Vice President’s Council on Competitiveness, and the White House Office of Policy Development, respectively. Marc began his career as an HIV researcher at the Midwest AIDS Behavioral Research Center in Ann Arbor. Marc speaks frequently on business strategy and policy matters. His comments and analyses have appeared in STAT News, The Pink Sheet, Fierce Healthcare, the Journal of Oncology Practice, Medical Economics, among other places. Marc earned his juris doctorate at the University of Texas, a master’s in public health from Yale School of Public Health, and a bachelor’s degree in neuropsychology from the University of Michigan. Marc is a visiting fellow at the Duke-Margolis Center for Health Policy, serves on the Board of Directors of NCCN Foundation, and is on the Advisory Board of the UCSF Rosenman Institute where he co-developed the Rosenman ADAPT and RISE programs, the later specifically created to advise and support founders from underrepresented groups to make the launch and scale of their health tech, digital or life science innovation as successful as possible.

Kirsten Sloan is senior policy director at the American Cancer Society Cancer Action Network. She leads ACS CAN ‘s policy work in support of the organization ‘s extensive federal, state, and local advocacy agendas. In addition, she manages a team of senior policy principals and analysts with a focus on access to care, emerging science, and prevention. Kirsten came to ACS CAN from the National Partnership for Women & Families, where she served as the vice president and helped manage the organization ‘s health policy portfolio. Before working for the National Partnership, she was director of federal health issues for AARP, leading advocacy efforts around Medicare and health care. Kirsten is a graduate of the University of Washington in Seattle.

Pat Wang joined Healthfirst as President and CEO in 2008 after serving as a senior executive overseeing payment policy at the Greater New York Hospital Association. Healthfirst was founded by 15 area hospital systems and was an early pioneer of value-based payment (VBP). Today, it is the largest not-for-profit health insurer in New York with 1.7 million Medicaid, Medicare Advantage, Affordable Care Act, and Long Term Care enrollees. It works in deep collaboration with its aligned provider partners to improve access, quality and outcomes for its members. Ms. Wang is completing her second term as a Commissioner on the Medicare Payment Advisory Commission (MedPAC), which advises the U.S. Congress on Medicare payment policy, and is on the boards of directors of America’s Health Insurance Plans (AHIP) and the New York Health Plan Association. She is a trustee of the Citizens Budget Commission, a non-partisan, non-profit civic organization focused on the well-being of future New Yorkers and was a member of New York’s second Medicaid Reform Taskforce which grappled with program reform in the midst of State budget shortfalls. She also co-chaired New York’s Vaccine Equity Taskforce where she worked with community leaders, organizations, and providers to ensure accurate information about and access to all populations to COVID-19 vaccines. Earlier in her career, Ms. Wang clerked for the Honorable Whitman Knapp, U.S. District Court Judge for the Southern District of New York and practiced health law in New York City.

Ronald Williams is chairman and CEO of RW2 Enterprises, LLC and is the former chairman and CEO of health insurance giant Aetna Inc. Mr. Williams is the bestselling author of “Learning to Lead: The Journey to Leading Yourself, Leading Others, and Leading an Organization”, developed from Mr. Williams’s own personal and professional journey, as well as the experiences of some of America’s leading CEOs. He is a graduate of Roosevelt University and holds an master’s in management from the Sloan School of Management at the Massachusetts Institute of Technology.

M. Roy Wilson is the president of Wayne State University. Prior to joining Wayne State, Dr. Wilson served as deputy director for strategic scientific planning and program coordination at the National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH). Previously, Dr. Wilson was dean of the School of Medicine and vice president for health sciences at Creighton University, president of the Texas Tech University Health Sciences Center, chancellor of the University of Colorado Denver/Anschutz Medical Campus and chair of the Board of Directors of University of Colorado Hospital. Dr. Wilson received his undergraduate degree from Allegheny College, a master’s degree in epidemiology from the University of California, Los Angeles, and a medical doctorate from Harvard Medical School.